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Purpose: Magnesium supplementation modulates glucose metabolism and inflammation, 
which could influence exercise performance and recovery. This study investigated magnesium 
intake on physiological responses and performance during eccentric exercise and recovery.  
Methods: Nine male recreational runners completed a counterbalanced, double-blind, placebo-
controlled, cross-over study, registered at ClinicalTrial.gov. Participants consumed low 
magnesium diets and were supplemented with 500 mg/day of magnesium (SUP) or placebo 
(CON) for 7-days prior to a 10 km downhill (-10%) running time-trial (TT), separated by a 2-
week washout period. At baseline and 24 hrs post TT maximal muscle force was measured. 
Interleukin-6 (IL-6), soluble interleukin-6 receptor (sIL-6R) and creatine kinase (CK) were 
measured at rest, 0 hr, 1 hr and 24 hrs post TT. Muscle soreness was measured at the previous 
times plus 48 hrs and 72 hrs post. Glucose and lactate were measured during the TT. 
Results: Main effect of condition were detected for IL-6 (SUP: 1.36 ± 0.66 vs CON: 2.06 ± 
1.14 pg/ml) (P < 0.05, η2 = 0.54), sIL-6R (SUP: 27615 ± 8446 vs CON: 24368 ± 7806 pg/ml) 
(P < 0.05, η2 = 0.41) and muscle soreness (P < 0.01, η2 = 0.67). Recovery of blood glucose and 
muscle soreness were enhanced in SUP post TT. There were no differences in glucose and 
lactate during the TT, or post measures of CK and maximal muscle force. 
Conclusion: Magnesium supplementation reduced the IL-6 response, enhanced recovery of 
blood glucose, and muscle soreness after strenuous exercise, but did not improve performance 
or functional measures of recovery. 
 
 
Key words: Magnesium; Interleukin-6; Exercise; Recovery; Glucose; muscle soreness 
 
Abbreviations: 
ANOVA Analysis of variance 
CI  Confidence interval 
CK  Creatine kinase 
ES  Effect size 
IL-6  Interleukin-6  
sIL-6R  Soluble interleukin-6 receptor  
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SD   Standard deviation 
TT  Time trial 
 
INTRODUCTION    
Magnesium is a highly abundant intracellular cation, which is involved in over 300 enzymatic 
reactions and plays an important role in the process of energy production and muscle function  
(Lukaski, 2000). The current recommended daily allowance for adult males is 400-420 mg/day  
(Institute of Medicine U.S., 1997). However, individuals meeting these requirements may still 
have an inadequate intake due to the low bioavailability of magnesium which ranges from 
approximately 10-75% in humans (Schuchardt & Hahn, 2017). A recent systematic review 
suggested that the recommended daily intake of magnesium is regularly not met and that some 
groups of athletes with particularly low intakes of magnesium rich foods may be up to 60% 
deficient (Heffernan, Horner, De Vito, & Conway, 2019). Further than this, it has been 
proposed that individuals who consistently take part in exercise may require a 10-20% higher 
intake of magnesium, in contrast to their sedentary counterparts (Nielsen & Lukaski 2006), and 
as such, athletes are susceptible to frequent short-term marginal disruptions in magnesium 
homeostasis, in part due to an increased loss of magnesium in sweat (Shirreffs & Maughan 
1997), increased excretion in the urine (Bohl & Volpe 2002), and low dietary magnesium 
intake (Heffernan et al. 2019). 
The efficacy of magnesium supplementation is currently unclear and difficult to consolidate as 
a result of differences in dietary magnesium intake, supplementation durations, and the nature 
of the exercise. Early studies of magnesium supplementation focused on chronic 
supplementation (Terblanche et al. 1992; Finstad et al. 2001), however these studies used 
relatively low doses (200-300 mg/day) and used subjects with normal dietary magnesium 
intakes. In contrast, higher doses of magnesium (300-500 mg/day) over relatively shorter 
periods (1-4 weeks) in participants with a low dietary magnesium intake have been shown to 
improve strength and fatigue resistance (Heffernan et al. 2019). In particular, a recent study 
suggested that 1-week of magnesium supplementation may be more advantageous than 4-
weeks (Kass & Poeira, 2015). 
There is growing evidence from animal studies that acute ingestion of high doses of magnesium 
can have rapid and important acute effects within a range of tissues. Several detailed studies 
have provided robust evidence that acute magnesium supplementation can increase glucose 
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availability within the blood, brain and muscle (peaking 60-80 min post ingestion), enhance 
lactate clearance within the brain and exercising muscle, and subsequently improved exercise 
performance (Chen et al. 2009; Cheng et al. 2010; Chen et al. 2014). To date no studies have 
examined the effects of short-term magnesium supplementation on glucose and lactate 
response to exercise in humans and these are important findings to investigate in humans. This 
is even more interesting when considering the recent evidence that high dose (500 mg/day) 
magnesium supplementation can reduce the post-exercise increase in the circulating 
concentration of the inflammatory cytokine IL-6 (Dmitrašinović et al. 2016), as IL-6 is thought 
to be involved in a wide number of processes that can impact exercise performance and 
recovery including. IL-6 is also thought to play a role in exercise induced fatigue (Vargas & 
Marino 2014), post exercise recovery and muscle soreness (Robson-Ansley et al. 2010) and 
has an established role in the modulation of glucose metabolism during exercise (Febbraio et 
al. 2003; Glund et al. 2007). Taken together it is conceivable that magnesium supplementation 
may increase glucose availability, thereby acting to reduce the IL-6 response to exercise, both 
of which may contribute to enhanced exercise performance or recovery. Unfortunately, the 
only study to investigate magnesium and IL-6 responses to exercise, did not measure functional 
aspects of exercise recovery such as force production, muscle damage or soreness 
(Dmitrašinović et al. 2016). 
When assessing the downstream effects of IL-6, it is also important to consider potential 
changes in its receptors, which are present in membrane bound and soluble forms. Importantly, 
the sIL-6R is thought to be involved in both glucose metabolism (Gray et al. 2009) and 
sensations of fatigue (Cullen et al. 2017; Robson-Ansley et al. 2010). Yet no studies have 
investigated whether sIL-6R is influenced by magnesium supplementation. As such, more 
comprehensive studies are required to fully elucidate the role of magnesium supplementation 
in the context of glucose metabolism and whether this may affect the modulation of IL-6 and 
it’s soluble receptor. Therefore, the aim of the current study was to investigate the effect of 
acute magnesium supplementation on exercise performance and functional recovery in 





Nine healthy male recreational endurance runners (age: 27 ± 4 years, body mass: 80 ± 11 kg 
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and height 180 ± 8 cm) participated in this repeated measure, counterbalanced, double blind 
crossover, placebo study. In the last year, participants on average ran 3 ± 1 times a week, a 
distance of 8 ± 3 km and had a 10 km personal best of 41 ± 4 min. Participants volunteered to 
participate in the study, completing informed consent and health screening forms. One 
participant withdrew from the study due to personal commitments. If the nutritional guidelines 
were not followed or participants had any form of injury / illness prior to testing, the participant 
was removed from the study. Ethical approval was agreed by the University Health Sciences 
Research Ethics Committee (SH17180029-R). 
 
Preliminary procedures 
Participants completed a baseline assessment of maximal force production of the knee extensor 
and flexor muscles, measured on an isokinetic dynamometer (Humac Norm Isokinectic 
dynamometer, CSMi Boston). Prior to all maximal leg contractions, participants were securely 
seated with their hip flexed at 90° and the knee joint in line with the dynamometer rotational 
axis. The dynamometer was set an angular velocity of 60°/s, with the range of motion of 0 - 
120° for the knee joint. In preparation for maximal effort, participants completed one set of 
concentric and eccentric leg extensions and flexions to practice the movement and a second set 
at 50% of maximal effort. After which, participants completed 3 sets of 5 maximal repetitions 
in both eccentric and concentric actions, with 30-seconds rest between sets, and a further 1-
minute rest between concentric and eccentric contractions. The dominant leg was tested in all 
participants and standardised verbal encouragement was provided to encourage maximal effort 
(Gandevia 2001). Peak torque was recorded as the highest torque output for an individual 
repetition across the 3 maximal sets. Participants were then thoroughly familiarised with the 
experimental protocol which is to be describe below.  
Dietary preparations were completed prior to commencing the first supplementation period. 
All capsules were identical in appearance, weight, and separated into coded bags for each 
participant. Before the first test session, participants were provided with a list of foods and 
beverages rich in magnesium. Participants were instructed in detail how to find and record the 
quantity of an item to complete the food diary. Portion sizes were provided through the weight 
or referenced estimation of an item. If the participants were unsure how to record a given item, 




Participants completed a counterbalanced, double-blind, placebo controlled, cross-over design. 
This study was post-hoc registered at ClinicalTrial.gov. Prior to the testing phase, participants 
completed baseline measurements of maximal force production of the knee extensor and flexor 
muscles on an isokinetic dynamometer (Humac Norm Isokinectic dynamometer, CSMi 
Boston). Participants were then randomly assigned to a supplementation (SUP) or placebo 
condition (CON) for a period of 7 consecutive days. On the 7th day of supplementation 
participants completed the experimental protocol consisting of a maximal effort 10 km 
downhill (-10% gradient) TT on a treadmill (h/p/cosmos mercury 4.0 h/p/cosmos sports & 
Medical GmbH, Nussdor-Traunstein, Germany), followed by assessments of muscular, 
perceptual and biochemical measures of recovery. This protocol has previously been shown to 
induce significant muscle and impair muscle function (Pokora et al. 2014), allowing for the 
assessment of performance and recovery. Following a two-week washout period, participants 
completed the experiment with the opposing treatment. A two-week washout period was 
deemed suitable as previous more intense acute magnesium depletion investigations observed 
that humans returned to baseline levels within 2-weeks (Lukaski & Nielsen, 2002), while more 
recent studies have used a 7-day washout period following 4-weeks of magnesium 
supplementation (Kass & Poeira, 2015). Both participants and investigators were blinded to 
the treatment until statistical analysis was completed. 
 
Experimental protocol 
In the week prior to each downhill 10 km TT, participants were instructed not to exceed 260 
mg/day of magnesium and required to consume either magnesium or placebo capsules (as 
described below). Following a 12 hr overnight fast, participants attended the laboratory and 
provided an initial venous blood sample from the median cubital vein. All laboratory visits 
were completed at the same time of day to control for differences in circadian rhythm. 
Following a short rest, participants subsequently completed a self-paced 10 km downhill TT 
whereupon participants had been instructed to complete the distance in the shortest possible 
time. The speed of the treadmill was regulated via verbal command from the participant 
through the researcher. Participants were provided with information regarding distance at every 
0.5 km. Strong verbal encouragement was provided throughout with the aim of facilitating 
maximal effort in each trial. At every 2 km, capillary blood samples were obtained from the 
fingertip and used for the assessment of blood glucose and lactate conducted on an automated 
benchtop analyser (Biosen C-Line Clinic, EKF-diagnostic GmbH, Barleben, Germany). These 
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values were then averaged to provide an overall assessment of glucose and lactate responses 
during the exercise (later described as ‘Dur’).  
Further venous blood samples were obtained immediately following completion of the exercise 
and after 1 hr of recovery. Participants then returned to the laboratory 24 hrs later, after a 12 hr 
overnight fast, to provide further blood samples and to complete an assessment of maximal 
isometric force production of the knee extensor and flexor muscles (as described above). This 
provided a measure of the recovery of mechanical force production following the 10 km 
downhill TT  (Eston et al. 1996). Immediately post the downhill 10 km TT, 24 hrs prior to 
maximal force testing, participants were reminded to avoid the use of recovery strategies, 
exercise and have sufficient sleep. Perceived muscle soreness was assessed using an ordinal 
visual analogue scale 0 (no pain) to 10 (unbearable pain) (Pincus et al. 2008; Robson-Ansley 
et al. 2010), at rest, immediately following completion of the 10 km downhill TT, 1 hr, 24 hrs, 
48 hrs and 72 hrs into recovery. The timeline of experiment is displayed in Fig.1. 
 
XXX Insert Figure 1 Here XXX 
 
Nutritional guidelines 
Participants were provided with a list of foods and beverages rich in magnesium and were 
instructed how to find and record the quantity of an item to complete the food diary. Examples 
of types of foods and beverages participants were recommended to avoid included almonds, 
spinach, cashews, soy milk, black beans, edamame and peanut butter. In this study, a low 
magnesium dietary intake was achieved by implementing a magnesium restricted diet of  <260 
mg/day, which is considered low for male athletic populations and if continued could lead to 
magnesium deficiency in the long term (Nielsen & Lukaski 2006). Food diaries were analysed 
using Nutritics (Nutritics LTD., Dublin, Ireland), to estimate the amount of dietary magnesium 
consumed and to confirm adherence to the dietary instructions. Over the 7-day supplementation 
period, prior to the experimental trial, participants consumed 3 capsules per day (8am, 2pm 
and 8pm). In the SUP condition this equated to a daily dose of 500 mg/day of magnesium 
(magnesium oxide, magnesium stearate, microcrystalline cellulose) (MyVitaminsTM), while 
the CON condition consumed capsules containing cornflour.  
Magnesium oxide has a relatively low solubility compared to other forms of magnesium 
(Blancquaert, Vervaet, & Derave, 2019), however, magnesium oxide supplementation has been 
shown to improve exercise performance in lower doses than the current study (Setaro et al., 
2014; Veronese et al., 2014). In an attempt to increase the bioavailability of magnesium, this 
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study implemented a supplementation regimen of low doses, at 6 hr intervals across the day 
(~80% of magnesium absorption), with a high overall total daily dose (500 mg). Each of the 
previously mentioned have been shown to enhance magnesium solubility (Fine, Santa Ana, 
Porter, & Fordtran, 1991; Hardwick, Jones, Brautbar, & Lee, 1990; Quamme, 2008), and the 
latter to increase absolute absorption (Schuchardt & Hahn, 2017). 
Capsules were double blinded from the researchers and participants, with the magnesium and 
placebo capsules being identical in appearance and weight. On the day of testing, the capsule 
was consumed after the final blood sample. Throughout the study participants avoided 
consumption of multivitamin supplements and anti-inflammatory medications. Participants 
were instructed to replicate their diet in the 24 hr period in-between the downhill 10 km TT 
and maximal force tests (including a 12 hr overnight fast).  
 
Blood sampling and analysis 
Whole blood samples (8 ml per time point) were collected into K3EDTA vacutainers (Greiner 
Bio-one; Frickenhausen, Germany). CK was measured immediately using an automated 
analyser (Reflotron plus, Roche Diagnostics GmbH, Rotkreuz, Switzerland). The remaining 
whole blood sample was separated by centrifugation at 3,000 x G for a 10-minute. The resultant 
plasma was then stored at -80°C until subsequent analysis. Plasma IL-6 concentrations were 
analysed using a high sensitivity enzyme linked immunosorbent assay (ELISA) (Quantikine 
HS; R&D Systems Ltd., Abingdon, UK). sIL-6R was measured using a commercially available 
DuoSet ELISA (R&D Systems Ltd.) that has previously been validated for use with plasma 
samples (Cullen et al. 2016). All additional reagents were purchased from R&D Systems Ltd. 
Prior to analysis of sIL-6R, plasma was diluted 1:100 in a commercially available diluent 
(DY997, R&D Systems Ltd) to produce concentrations that were within the dynamic range of 
the assay. In order to minimise variation, all samples from an individual participant were 
analysed in the same assay and the manufacturer’s instructions were carried out at all times. 
IL-6 and sIL-6R concentrations were corrected for changes in plasma volume, which were 
calculated using established methods (Dill & Costill 1974). The IL-6 assay has a detection limit 
of 0.031 pg/ml and had an intra-assay coefficient of variation of 3.9 ± 0.2 % across a range of 
0.15 - 10 pg/ml. The sIL-6R assay has an intra-assay coefficient of variation of 4.8 ± 1.6 % 
across a range of 1.56 - 100 ng/ml. IL-6 and sIL-6R concentrations were identified in 




Data normality were confirmed through the use of the Shapiro-Wilk test. In order to assess a 
potential carryover effect a Fisher’s exact test was used and subsequently confirmed no 
carryover effect. A paired samples t-test was utilised to assess the effect of magnesium 
supplementation on downhill 10 km TT performance. In order to assist with the interpretation 
of the practical significance of this result, effect size (ES) was measured (Cohen, 1988). A one-
way repeated measures ANOVA was utilised to assess the difference in peak torque between 
Baseline, CON and SUP conditions. A two-way repeated measures ANOVA (treatment 
[placebo vs magnesium] × time) was used to assess the effect of supplementation on blood 
glucose, IL-6 and sIL-6R responses to exercise. Corresponding effect sizes for main effects 
were calculated as partial eta squared (η2). When main effects were identified, post-hoc 
analysis was performed using simple pairwise comparisons with Bonferroni adjustment. A 
post-hoc power analysis was carried out on the primary and secondary variables (IL-6 & 
glucose) using G*power 3.1. A Friedman test was utilised to measure differences between 
conditions for muscle soreness. On the occurrence of a significant result, a Wilcoxon test was 
then utilised to identify the differences at specific time points between conditions. Pearson 
correlations were used to investigate relationships between measures of performance and 
recovery, and biochemical variables. All data was expressed as mean ± standard deviation (SD), 
with statistical significance was set at P < 0.05. Statistical analyses were undertaken using 





Dietary mineral, trace elements and macronutrients  
Analysis of food diaries demonstrated that participants adhered to the magnesium restricted 
diet of <260 mg/day. There was no difference in reported dietary magnesium consumption 
between conditions (SUP = 197 ± 61 mg/day vs CON = 215 ± 52 mg/day, P > 0.05). A 
significant difference was apparent between conditions with the inclusion of 500 mg/day of 
magnesium for the SUP condition (SUP = 697 ± 61 mg/day vs CON = 215 ± 52 mg/day, P < 
0.001). Significant differences were also observed between conditions for sodium and chloride 
(P < 0.05). 
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XXX Insert Table 1 Here XXX 
 
10 km TT performance 
There was no effect of supplementation on 10 km downhill running TT performance (SUP = 
39:49 ± 4 min vs CON = 41:01 ± 3 min, P = 0.2, ES= 0.46). Performance was faster in 7 out 
of 9 participants in SUP than CON, which was equivalent to an average 72 seconds (4%) faster 
10 km run time. 
XXX Insert Figure 2 Here XXX 
 
IL-6, sIL-6R, glucose and lactate responses to exercise  
Exercise induced changes in the plasma concentration of IL-6 and sIL-6R are reported in Fig. 
3. Main effects of condition (F = 9.329, P = 0.016, η2 = 0.538) and time (F = 18.739, P < 0.001 
η2 = 0.701) were observed for IL-6. IL-6 was significantly lower during SUP (1.36 ± 0.66 
pg/ml) than CON (2.06 ± 1.14 pg/ml) (P = 0.016, mean difference= 0.7 pg/ml, 95%CI: 0.17 - 
1.23 pg/ml). Post-hoc power analysis revealed an adequate power of pβ > 0.96 % for IL-6 
(Cohen 1988). From pre-exercise, plasma IL-6 concentrations increased immediately post (P 
= 0.004, mean difference= 2.1 pg/ml, 95%CI: 0.72 - 3.50 pg/ml) and 1 hr post (P = 0.012, mean 
difference=1.85 pg/ml, 95%CI: 0.41 - 3.29 pg/ml) downhill 10 km TT. At 24 hrs post, plasma 
IL-6 was not significantly different to rest (P = 0.78), appearing to return to baseline levels. 
For sIL-6R the ANOVA revealed a main effect of condition (F = 5.660, P = 0.045, η2 = 0.41) 
with sIL-6R higher in the SUP (27615 ± 8446 pg/ml) than CON (24368 ± 7806 pg/ml) (P = 
0.045, mean difference= 3064 pg/ml, 95%CI: 94 - 6035 to pg/ml). Correlation analysis did not 
reveal any relationships between IL-6 and sIL-6R and measures of performance or recovery. 
 
XXX Insert Figure 3 Here XXX 
 
Blood glucose and lactate responses are reported in Fig. 4. There was no significant effect of 
condition on blood glucose, but there was a time effect (F = 20.828, P < 0.001, η2 = 0.722). 
Post-hoc power analysis revealed an adequate power of pβ > 0.80 % for glucose. Blood glucose 
concentrations were increased immediately post 10 km downhill TT (P = 0.002, mean 
difference= 1.1 mmol/L, 95%CI: 0.453 - 1.792 mmol/L), thereafter returning to resting levels 
in the SUP condition and below resting in the CON condition. There was a significant time x 
condition interaction effect, with glucose being significantly higher in SUP than CON at 1 hr 
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post (4.46 ± 0.15 mmol/L vs 3.72 ± 0.22 mmol/L, P = 0.005, mean difference= 0.7 mmol/L, 
95%CI: 0.29 - 1.17 to mmol/L) and 24 hrs post exercise (4.40 ± 0.11 mmol/L vs 3.89 ± 0.15 
mmol/L, P = 0.04, mean difference= -0.51 mmol/L, 95%CI: -0.98 to -0.03 mmol/L). 
There was a main effect of time for blood lactate (F = 36.656, P < 0.001, η2 = 0.821), increasing 
during exercise (P = 0.008, mean difference= 2.2 mmol/L, 95%CI: 0.59 - 3.82 mmol/L), and 
peaking immediately post the 10 km downhill TT (P = 0.002, mean difference= 4.4 mmol/L, 
95%CI: 1.87 - 7.08 mmol/L), thereafter returning to resting levels. There were no effects of 
condition (F = 3.2, P = 0.11, η2 = 0.28) or interaction effects (F = 0.67, P = 0.61, η2 = 0.08).  
 
XXX Insert Figure 4 Here XXX 
 
Measures of recovery 
Main effects of condition were detected for peak torque of concentric extensors (F = 10.269, P 
= 0.003, η2 = 0.562), concentric knee flexors (F = 9.641, P = 0.004, η2 = 0.547), eccentric knee 
flexors (F = 6.212, P = 0.013, η2 = 0.437). Peak concentric knee extensor force was 
significantly decreased from baseline in SUP (P = 0.021, mean difference= -36 Nm/kg, 95%CI: 
-5.69 to -66.30 Nm/kg) and CON (P = 0.004, mean difference= -30 Nm/kg, 95%CI: -11.14 to 
-49.75 Nm/kg), demonstrating a significant impairment in muscle force production 24 hrs post 
10 km downhill TT. No significant differences were detected between SUP and CON, 
demonstrating no effect of the intervention (Fig. 5a). Peak concentric knee flexors torque was 
significantly decreased from Baseline to SUP (P = 0.029, mean difference= -32 Nm/kg, 95%CI: 
-3.386 to -60.170 Nm/kg) and CON (P = 0.028, mean difference= -31 Nm/kg, 95%CI: -3.66 to 
-61.0 Nm/kg), with no difference between SUP and CON (Fig. 5c). Peak eccentric knee flexor 
torque was significantly decreased from Baseline to SUP (P = 0.04, mean difference= -20 
Nm/kg, 95%CI: -0.68 to -40.65 Nm/kg) and CON (P = 0.004, mean difference= -22 Nm/kg, 
95%CI: -3.6 to -40.85 Nm/kg), but with no difference between SUP and CON (Fig. 5d). 
 
XXX Insert Figure 5 Here XXX 
 
Circulating CK showed a main effect of time (F = 6.231, P = 0.029, η2 = 0.438), however post-
hoc testing revealed no consistent pattern to the data. There was no significant effect of 
condition (F = 0.5, P = 0.5, η2 = 0.059) (Fig. 6a). 
Muscle soreness showed a main effect of condition (F = 16.112, P = 0.004, η2 = 0.668) and 
time F = 28.928, P < 0.001 η2 = 0.783), while there was also an interaction effect (F = 2.7, P = 
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0.03, η2 = 0.26). Muscle soreness increased immediately post (P < 0.001, mean difference= 6.8, 
95%CI: 4.19 - 9.58), 1 hr post (P = 0.003, mean difference= 2.4, 95%CI: 0.86 - 3.91), 24 hrs 
post (P = 0.008, mean difference= 3.2, 95%CI: 0.87 - 5.69), 48 hrs post (P = 0.009, mean 
difference= 3.0, 95%CI: 0.77 - 5.35), and 72 hrs post downhill 10 km TT (P = 0.016, mean 
difference= 1.6, 95%CI: 0.29 - 3.041) (Fig. 6b). CON was significantly higher than SUP at 24 
hrs (P = 0.038, mean difference= 1.44, 95%CI: 0.11 - 2.78), 48 hrs (P = 0.021, mean 
difference= 2.33, 95%CI: 0.45 - 4.22), and 72 hrs post (P = 0.049, mean difference= 1.55, 
95%CI: 0.13 - 3.09). This corresponded to 32 ± 11 %, 50 ± 14 % and 53 ± 12 % lower muscle 
soreness in SUP than CON at 24 hrs, 48 hrs and 72 hrs respectively. 
 




The primary results of this study are that 7-days of 500 mg/day magnesium supplementation in 
comparison to 7 days of low magnesium intake (<260 mg/day) causes a significant decrease in 
the circulating concentration of IL-6, while increasing sIL-6R, but did not result in significant 
improvements in performance, nor recovery of strength and muscle damage in the 24 hrs 
following a downhill 10 km running time-trial. Magnesium supplementation did not increase 
blood glucose concentration during exercise nor reduce blood lactate, but increased blood 
glucose 1-24 hrs post exercise, and reduced muscle soreness 24-72 hrs after the exercise. Taken 
together these findings provide further evidence of the potential positive physiological effects 
of magnesium supplementation, but do not provide evidence for it as an ergogenic aid in this 
context during acute exercise. 
These novel findings extend our understanding of the physiological effects of magnesium 
supplementation by demonstrating a reduction in IL-6 and increase in the sIL-6R. The 
interaction of IL-6 and sIL-6R is highly complex and likely context dependent, however, the 
decrease in sIL-6R observed in the CON condition, might be explained through an increased 
formation of IL-6/sIL-6R complexes, due to the elevated IL-6 production (Baran et al. 2018). 
Post exercise inflammation, in the form of transient increases of muscle derived IL-6, has an 
anti-inflammatory effect protecting against insulin resistance, stimulating lipolysis and 
increasing fat oxidation (Petersen & Pedersen, 2005). The anti-inflammatory response is 
essential for post exercise adaptations and preventing it can hinder recovery (Mackey et al., 
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2007; Mikkelsen et al., 2009; Wedell-Neergaard et al., 2019). However, inflammation also 
causes fibrosis (Abdelmagid et al., 2012) and induces pain (Stauber, 2004). Therefore, in 
situations of repeated muscle damage, when muscle soreness is prolonged in nature, attenuating 
inflammation and muscle soreness may enhance ones perceived ‘readiness to train’ or indeed 
performance. This could be particularly important for athletes during intensified training blocks, 
periods of fixture congestion in team sports, repeated competition over series of days such as 
major tennis tournaments, and strenuous multiple day athletic events. 
Many previous studies have discussed the potential role of IL-6 during exercise, with increased 
circulating IL-6 concentrations often being associated with impaired subsequent exercise 
performance (Robson-Ansley et al. 2004; Walshe et al. 2010). Yet, we observed no respective 
improvement in performance despite lower concentrations of IL-6 and higher concentrations 
of sIL-6R. It is possible that in circumstances of intensified training or overreaching, when IL-
6 may be chronically elevated (Robson-Ansley et al. 2007), that magnesium supplementation 
may have a beneficial effect. As such, future studies should investigate the efficacy of 
magnesium supplementation in periods of intensified training or repeated competition.  
Previous studies are inconsistent regarding the efficacy of magnesium supplementation for 
improving performance and recovery from exercise. Our findings are in agreement with 
previous studies that magnesium supplementation does not enhance endurance performance or 
recovery in the context of a single bout of acute exercise in young athletic cohorts  (Terblanche 
et al. 1992; Finstad et al. 2001). However, contradictory findings have been observed in elderly 
populations, using chronic magnesium supplementation in a longitudinal setting (Veronese et 
al. 2014); yet it is unclear whether magnesium supplementation is particularly beneficial in 
elderly populations or whether magnesium supplementation is simply more effective in the 
context of repeated exposure to exercise. It is also feasible that the effects observed in the 
current study were too small, or too inconsistent, to have a statistically significant effect on 
exercise performance. Indeed, performance was on average 71 seconds (4%) faster in SUP than 
CON, which equated to a moderate effect size (0.46), and while not statistically significant this 
may represent an important effect for practitioners seeking to improve performance by small 
margins in individual athletes.  
In contrast to the effects observed in murine models (Cheng et al. 2010; Chen et al. 2014), we 
observed no effect of magnesium supplementation on blood glucose or lactate concentration 
during exercise. The aforementioned studies by Chen and colleagues observed large increases 
in blood glucose (up to 175%) following infusion of a very high dose of magnesium (equivalent 
to approximately 10 times the daily dose used in the current study). As such, it appears that 
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even the high dose used in the current study is not sufficient to induce the beneficial effects 
observed by Chen and colleagues. In humans, higher doses (>500 mg·day-1) should be 
investigated with caution given the well-established laxative and gastrointestinal side effects 
(Portalatin & Winstead 2012). In contrast, blood glucose concentration was higher post 
exercise, which is in accordance with previous studies (Chen et al. 2009). This is thought to be 
connected to both magnesium and the Mg-ATP complex being critical for the availability of 
glucose via glucose metabolism, as a cofactor in glycolysis for phosphofructokinase, 
hexokinase, phosphoglycerate kinase, pyruvate kinase, and aldolase (Garfinkel & Garfinkel 
1985). In addition to magnesium status regulating the expression and translocation of glucose 
transporter type 4 (GLUT4) (Romani et al. 2000; Kamran et al. 2018; Solaimani et al. 2014). 
This may have assisted in upholding glucose homeostasis during exercise, in turn leading to 
glycogen stores being less depleted in the SUP condition. This could also explain the observed 
lower IL-6 concentrations in the SUP condition post exercise. As GLUT4 is considered critical 
for the replenishment of glycogen stores post exercise (McCoy, Proietto, & Hargreaves, 1996), 
future studies should investigate the potential for magnesium supplementation to increase 
muscle glycogen repletion, as this may have important consequences in circumstances of 
repeated training and competition.  
There was no effect of magnesium supplementation on muscle damage, as measured by CK 
concentration, nor maximal muscle force, but it did reduce perceived muscle soreness 48-72 
hrs post exercise. Given that IL-6 has been implicated in the perception of pain (De Jongh et 
al. 2003) and exercise induced muscle soreness via trans-signalling through sIL-6R (Robson-
Ansley et al. 2010), we also investigated the relationship between IL-6, sIL-6R and muscle 
soreness. Despite a reduction in IL-6 and decrease in muscle soreness at 24-72 hrs post exercise, 
there were no relationships between changes in IL-6, sIL-6R and perceived muscle soreness. 
Therefore, the observed positive effects on post exercise muscle soreness are likely due to 
another mechanism.  
 
Limitations 
It is important to acknowledge that the current study is not without limitation. We did not 
directly assess any potential changes in cellular magnesium concentration. Given that the 
observed responses in terms of IL-6, blood glucose and muscle soreness are likely due to 
molecular signalling events happening within the muscle, it would have been particularly 
interesting to assess any potential effects of supplementation on acute magnesium fluctuations 
within the muscle. Ultimately these measurements were beyond the scope of the current study. 
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Finally, a 10 km TT at baseline and the assessment of blood biomarkers during exercise, 48 




In summary, the results of our study indicate that short-term magnesium supplementation 
decreases plasma IL-6 concentration and has small positive effects on blood glucose and 
muscle soreness in the days following strenuous exercise. However, there was no beneficial 
effect on exercise performance, recovery of muscle force or muscle damage. Future studies 
should investigate the effects of magnesium supplementation in situations of repeated muscle 
damage and inflammation where the potential negative effects accumulate over several days. 
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Table and Figure Captions 
Table 1 Minerals, trace elements and macronutrients during the 1-week controlled magnesium 
dietary intake in the magnesium supplemented (SUP) and low magnesium diet (CON) 
conditions. All values are mean ± standard deviation. 
 
Fig. 1 Chronological schematic representing the experimental protocol, including 
supplementation periods, 10 km time trials, isokinetic dynamometer testing and venous blood 
sample time points. 
 
Fig. 2 10 km downhill running time trial performance in the magnesium supplemented (SUP) 
and low magnesium diet (CON) conditions. Individual data points represent performance times 
of each participants, while lines and whiskers represent mean and SD respectively. 
 
Fig. 3 Circulating IL-6 (A), sIL-6R (B) responses to 10 km downhill time trial in the 
magnesium supplemented (SUP) and low magnesium diet (CON) conditions. 
a = main effect of condition  
b = main effect of time  
c = significantly different to Pre and 24 hrs 
 
Fig. 4 Blood glucose (A) and lactate (B) responses to 10 km downhill time trial in the 
magnesium supplemented (SUP) and low magnesium diet (CON) conditions. ‘Dur’ represents 
the mean measurement taken throughout exercise the exercise. 
a = main effect of condition  
b = significantly different to all other time points 
c = significant difference between SUP and CON 
 
Fig. 5 Peak torque of the concentric extensors (a), eccentric extensors (b), concentric flexors 
(c) and eccentric flexors (d) at baseline and 24 hrs post 10 km downhill time trial in the 
magnesium supplemented (SUP) and low magnesium diet (CON) conditions. 
a = main effect of time  
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b = significantly different to Baseline 
 
Fig. 6 Creatine kinase (A) and muscle soreness (B) in responses to 10 km downhill time trial 
in the magnesium supplemented (SUP) and low magnesium diet (CON) conditions. 
a = main effect of condition 
b = main effect of time 
c = significantly different to Pre and Post 
d = significantly different to all other time points 
e = significant difference between SUP and CON 
